**Core Concept**
Tamoxifen is a selective estrogen receptor modulator (SERM) used primarily in the treatment and prevention of breast cancer. It acts by binding to estrogen receptors on breast cancer cells, thereby inhibiting the growth-promoting effects of estrogen.

**Why the Correct Answer is Right**
Tamoxifen has a unique mechanism of action, where it acts as an estrogen agonist in certain tissues, such as the uterus and bone, while acting as an antagonist in breast tissue. This dual action is responsible for its therapeutic effects in breast cancer patients. The correct answer is related to the side effects that are not commonly associated with tamoxifen use.

**Why Each Wrong Option is Incorrect**
**Option A:** Endometrial cancer is actually a known side effect of tamoxifen due to its estrogen agonist activity in the uterus, leading to an increased risk of endometrial cancer.

**Option B:** Osteoporosis is a potential side effect of tamoxifen, particularly in postmenopausal women, due to its estrogen antagonist activity in bone tissue, which can lead to bone loss and increased risk of fractures.

**Option C:** Hot flashes are not a direct side effect of tamoxifen, but rather a symptom of estrogen withdrawal, which can occur in postmenopausal women taking tamoxifen.

**Clinical Pearl / High-Yield Fact**
Tamoxifen has a unique "window of opportunity" for the prevention of breast cancer, where its use is most effective in premenopausal women with a high risk of breast cancer. This is due to its ability to inhibit estrogen-induced breast cancer cell growth.

**Correct Answer:** C. Hot flashes.